Incannex Healthcare (IXHL) Shares Outstanding (Diluted Average) (2022 - 2026)

Incannex Healthcare's (IXHL) quarterly Shares Outstanding (Diluted Average) came in at $12.3 million in Q1 2026, up 1931.12% year-on-year from $607962.0 in Q1 2025, and down 96.47% quarter-over-quarter from $349.5 million in Q4 2025.

Incannex Healthcare (IXHL) Shares Outstanding (Diluted Average) (2022 - 2026) Analysis & Trends

Incannex Healthcare has disclosed Shares Outstanding (Diluted Average) across 5 years of filings, most recently posting $12.3 million for Q1 2026.

  • Shares Outstanding (Diluted Average) for Q1 2026 came in at $12.3 million, up 1931.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.3 million (up 1931.12% YoY), and the FY2025 annual result was $34.5 million, up 113.15% from the prior year.
  • Shares Outstanding (Diluted Average) came in at $12.3 million for Q1 2026 at Incannex Healthcare, down from $349.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $349.5 million in Q4 2025 to a low of $607962.0 in Q1 2025.
  • The 5-year median for Shares Outstanding (Diluted Average) is $15.9 million (2023), against an average of $60.9 million.
  • Across the five-year window, Shares Outstanding (Diluted Average) tumbled 96.17% in 2025 and surged 1931.12% in 2026, its largest moves.
  • Incannex Healthcare's Shares Outstanding (Diluted Average) stood at $14.9 million in 2022, then advanced by 6.52% to $15.9 million in 2023, then climbed by 10.65% to $17.6 million in 2024, then soared by 1889.75% to $349.5 million in 2025, then slumped by 96.47% to $12.3 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $12.3 million (Q1 2026), $349.5 million (Q4 2025), and $310.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.18 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.40 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 47.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 103.40 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 506.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Incannex Healthcare 45.81 Mn 45.81 Mn - 12.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.35 Mn
Dec 31, 2025 349.46 Mn
Sep 30, 2025 310.31 Mn
Jun 30, 2025 34.45 Mn
Mar 31, 2025 607,962.00
Dec 31, 2024 17.56 Mn
Sep 30, 2024 17.64 Mn
Jun 30, 2024 16.16 Mn
Mar 31, 2024 15.87 Mn
Dec 31, 2023 15.87 Mn
Sep 30, 2023 15.87 Mn
Jun 30, 2023 15.38 Mn
Mar 31, 2023 15.87 Mn
Dec 31, 2022 14.90 Mn